Home » News » Autism Risk May be Linked to Mother’s Depression, Not Medication
Autism Risk May be Linked to Mother’s Depression, Not Medication

Autism Risk May be Linked to Mother’s Depression, Not Medication

The debate continues on whether prenatal antidepressant use increases the risk of autism among children.

New research suggests prior findings that show an increased risk of autism after medication use, may actually reflect the known increased risk associated with severe maternal depression.

The new study by researchers from Massachusetts General Hospital (MGH) is receiving advance online publication in the journal Molecular Psychiatry.

Investigators discovered that while a diagnosis of autism spectrum disorder was more common in the children of mothers prescribed antidepressants during pregnancy than in those with no prenatal exposure, when the severity of the mother’s depression was accounted for, that increased risk was no longer statistically significant.

Investigators did, however, discover that an increased risk for attention-deficit hyperactivity disorder (ADHD) persisted even after controlling for factors relating to a mother’s mental health.

“We know that untreated depression can pose serious health risks to both a mother and child, so it’s important that women being treated with antidepressants who become pregnant, or who are thinking about becoming pregnant, know that these medications will not increase their child’s risk of autism,” said Roy Perlis, M.D., M.Sc., M.G.H., senior author of the report.

The authors note that, while genetic factors are known to play a substantial role in autism, exactly how that risk may be exacerbated by environmental factors is not well understood.

While animal studies and investigations based on health records have suggested an increased risk associated with prenatal antidepressant exposure, others found no such association.

And since discontinuing antidepressant treatment significantly increases the risk of relapse — including an increased risk of postpartum depression — the current study was designed to clarify whether or not any increased autism risk could actually be attributed to the medication.

For the study, researchers analyzed electronic health record data for children born at MGH, Brigham and Women’s Hospital, or Newton Wellesley Hospital — hospitals belonging to Partners HealthCare System — for whom a diagnostic code for pervasive developmental disorder, a category that includes autism, was entered at least once between 1997 and 2010.

They matched data for almost 1,400 such children with that of more than 4,000 controls with no autism diagnoses, born the same years and matched for a variety of demographic factors.

The children’s information was paired with that of their mothers, noting any factors related to the diagnosis and treatment of major depression or other mental illness, including prescriptions for antidepressants and other psychotropic drugs.

A similar analysis was done for almost 2,250 children with an ADHD diagnosis, compared with more than 5,600 matched controls with no ADHD diagnoses.

While prenatal exposure to antidepressants did increase the risk for either condition, in the autism-focused comparison, adjusting for factors indicating more severe maternal depression reduced the strength of that association to an insignificant level.

Taking antidepressants with stronger action in the serotonin pathway, which has been suspected of contributing to a possible autism risk, did not increase the incidence of the disorder.

In addition, the children of mothers who took a serotonin-targeting non-antidepressant drug for severe morning sickness had no increased autism incidence.

Prescriptions for antipsychotic drugs sometimes used to treat severe, treatment-resistant depression, as well as psychotic disorders, did appear to increase the risk for autism.

For ADHD, however, the increased risk associated with prenatal antidepressant exposure remained significant, although reduced, even after adjustment for the severity of maternal depression.

“There are a range of options — medication and non-medication — for treating depression and anxiety in pregnancy,” said Perlis, an associate professor of psychiatry at Harvard Medical School.

“But if antidepressants are needed, I hope parents can feel reassured about their safety.”

Source: Massachusetts General Hospital

 

Pregnant woman taking antidepressant photo by shutterstock.

Autism Risk May be Linked to Mother’s Depression, Not Medication

Rick Nauert PhD

Rick Nauert, PhDDr. Rick Nauert has over 25 years experience in clinical, administrative and academic healthcare. He is currently an associate professor for Rocky Mountain University of Health Professionals doctoral program in health promotion and wellness. Dr. Nauert began his career as a clinical physical therapist and served as a regional manager for a publicly traded multidisciplinary rehabilitation agency for 12 years. He has masters degrees in health-fitness management and healthcare administration and a doctoral degree from The University of Texas at Austin focused on health care informatics, health administration, health education and health policy. His research efforts included the area of telehealth with a specialty in disease management.

APA Reference
Nauert PhD, R. (2015). Autism Risk May be Linked to Mother’s Depression, Not Medication. Psych Central. Retrieved on May 23, 2018, from https://psychcentral.com/news/2014/08/27/autism-risk-may-be-linked-to-mothers-depression-not-medication/74148.html

 

Scientifically Reviewed
Last updated: 6 Oct 2015
Last reviewed: By John M. Grohol, Psy.D. on 6 Oct 2015
Published on PsychCentral.com. All rights reserved.